BC080695 Activators
NM_001007579 Activators encompass a range of chemical compounds that could influence the functional activity of NM_001007579 by targeting various signaling pathways and biological processes. Forskolin, by increasing cAMP levels, could enhance NM_001007579 activity by promoting PKA signaling, potentially leading to phosphorylation of the protein or its regulatory factors. Epigallocatechin gallate, as a kinase inhibitor, and Genistein, as a tyrosine kinase inhibitor, might reduce inhibitory phosphorylation or competitive signaling, respectively, thereby enhancing NM_001007579 activity. Sphingosine-1-phosphate could activate G-protein-coupled pathways, while PMA, a PKC activator, might phosphorylate substrates within NM_001007579-associated pathways. Ionomycin and A23187, both of which increase intracellular calcium, could potentiate NM_001007579 activity through calcium-dependent signaling cascades.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits several protein kinases, which could reduce inhibitory phosphorylation events and thus enhance NM_001007579 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which could lead to downstream signaling enhancing NM_001007579 activity through G-protein-coupled pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate substrates involved in pathways enhancing NM_001007579 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which could activate calcium-dependent signaling pathways and indirectly enhance NM_001007579 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 could shift cellular signaling in a way that enhances NM_001007579 activity by reducing competitive survival signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
By inhibiting p38 MAPK, SB203580 could modify the signaling equilibrium to favor pathways associated with NM_001007579 activation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that could shift signaling dynamics to enhance NM_001007579 activity by reducing ERK pathway signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This calcium ionophore increases intracellular calcium levels, potentially enhancing NM_001007579 activity through calcium-dependent signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Despite being a broad-spectrum kinase inhibitor, Staurosporine might enhance NM_001007579 activity by selectively inhibiting kinases that negatively regulate NM_001007579-associated pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased intracellular calcium levels that could enhance NM_001007579 activity through calcium-mediated signaling. | ||||||